University of Tuebingen

Tübingen D-72076

2 studies enrolling now · 10 studies all time

What they study most

Apnea of Prematurity, CPSS (Congenital Portosystemic Shunt), Congenital Portosystemic Shunt, Malignant Melanoma, Metastatic Castration Resistant Prostate Cancer, Parkinson Disease, Prostate Cancer, Stargardt's Macular Dystrophy

Studies at this site

• PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort — Recruiting now
• Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1) — Completed
• Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI — Completed
• A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed
• International Registry of Congenital Portosystemic Shunt (IRCPSS) — Enrolling by invitation
• Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression — Completed
• A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed
• Caffeine for Apnea of Prematurity (CAP) — Completed
• Vaccine Therapy for Patients With Stage IV Melanoma — Status unconfirmed
• Vaccine Therapy for Patients With Stage III Melanoma — Status unconfirmed